Boston Scientific Corporation (NYSE: BSX) announces it has entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company. Cortex is a privately held medical technology company focused on the development of a diagnostic mapping solution which may identify triggers and drivers outside of the pulmonary veins that are foundational to atrial fibrillation (AF), a heart rhythm disorder affecting nearly 38 million people globally. “We believe the addition of the Cortex technology complements our electrophysiology portfolio with a differentiated cardiac mapping offering to assist with complex AF cases,” said Nick Spadea-Anello, global president, Electrophysiology, Boston Scientific.
Read the full article: Boston Scientific Announces Agreement to Acquire Cortex, Inc. //
Source: https://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-cortex-inc-302294844.html